Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL

Not Applicable

Terminated

Conditions: Lymphoma

Interventions: Biological: Pegylated interferon α-2b
Other: Psoralens with ultraviolet light A
Other: Narrowband-ultraviolet light B

First Posted Date: 2008-07-29

Last Posted Date: 2018-12-12

Lead Sponsor: Northwestern University

Target Recruit Count: 7

Registration Number: NCT00724061

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Effectiveness of a Technology Assisted Behavioral Intervention in Assisting People With Major Depressive Disorder

Phase 1

Completed

Conditions: Depression

Interventions: Behavioral: Treatment as usual / Wait-list control
Behavioral: Behavioral intervention (iCBT + TeleCoach)
Behavioral: Internet-based cognitive behavioral therapy (I-CBT)

First Posted Date: 2008-07-22

Last Posted Date: 2014-03-19

Lead Sponsor: Northwestern University

Target Recruit Count: 102

Registration Number: NCT00719979

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: bevacizumab
Drug: erlotinib hydrochloride

First Posted Date: 2008-07-22

Last Posted Date: 2018-10-26

Lead Sponsor: Northwestern University

Target Recruit Count: 115

Registration Number: NCT00720356

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
Neuro-Oncology Associates at Baylor University Medical Center, Dallas, Dallas, Texas, United States
🇺🇸
Northwestern University, Northwestern Medical Faculty Foundation, Chicago, Illinois, United States

and more 6 locations

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer

Phase 2

Completed

Conditions: Esophageal Cancer

Interventions: Drug: Induction Therapy - Capecitabine
Drug: Induction Therapy - Oxaliplatin
Drug: Combination Therapy - Capecitabine
Drug: Combination Therapy - Oxaliplatin
Radiation: Combination Therapy - Radiation
Procedure: Evaluation for response and surgery

First Posted Date: 2008-07-08

Last Posted Date: 2018-07-18

Lead Sponsor: Northwestern University

Target Recruit Count: 44

Registration Number: NCT00711412

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor

Phase 1

Completed

Conditions: Gastric Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: docetaxel
Drug: fluorouracil
Drug: oxaliplatin

First Posted Date: 2008-07-08

Last Posted Date: 2019-02-26

Lead Sponsor: Northwestern University

Target Recruit Count: 59

Registration Number: NCT00711243

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors

Completed

Conditions: Skin Rash

Interventions: Procedure: Skin Biopsy of Skin Rash Secondary to EGFRI Use

First Posted Date: 2008-07-03

Last Posted Date: 2015-03-17

Lead Sponsor: Northwestern University

Target Recruit Count: 32

Registration Number: NCT00709878

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])

Phase 3

Completed

Conditions: Peripheral Vascular Diseases
Cardiovascular Diseases

Interventions: Behavioral: Group mediated cognitive behavioral (GMCB) sessions
Other: Health education sessions

First Posted Date: 2008-06-09

Last Posted Date: 2015-10-29

Lead Sponsor: Northwestern University

Target Recruit Count: 194

Registration Number: NCT00693940

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

Sorafenib-induced Hand- Foot Skin Reaction Treatment

Phase 2

Terminated

Conditions: Hand-foot Skin Reaction
Rash

Interventions: Drug: urea 40% cream
Drug: fluocinonide 0.05% cream
Drug: tazarotene 0.1% cream
Drug: bland emollient cream (Udderly smooth® Udder Cream)

First Posted Date: 2008-04-28

Last Posted Date: 2013-06-05

Lead Sponsor: Northwestern University

Target Recruit Count: 6

Registration Number: NCT00667589

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

Primary Care Community Partnerships to Prevent Diabetes

Not Applicable

Completed

Conditions: Hyperglycemia
Diabetes Mellitus
Obesity

Interventions: Behavioral: Dietitian Counseling Alone
Behavioral: Dietitian Plus Community Group Lifestyle

First Posted Date: 2008-04-11

Last Posted Date: 2018-03-29

Lead Sponsor: Northwestern University

Target Recruit Count: 509

Registration Number: NCT00656682

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])

Completed

Conditions: Coronary Disease
Cardiovascular Diseases

First Posted Date: 2008-02-29

Last Posted Date: 2023-05-03

Lead Sponsor: Northwestern University

Target Recruit Count: 1395

Registration Number: NCT00626379

Locations: 🇺🇸
Preventive Medicine Research Clinic, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy